These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25161890)

  • 21. Variation in the FFAR1 gene modifies BMI, body composition and beta-cell function in overweight subjects: an exploratory analysis.
    Walker CG; Goff L; Bluck LJ; Griffin BA; Jebb SA; Lovegrove JA; Sanders TA; Frost GS;
    PLoS One; 2011 Apr; 6(4):e19146. PubMed ID: 21552566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An updated patent review of GPR40/ FFAR1 modulators (2020 - present).
    Ren Q; Fan Y; Yang L; Shan M; Shi W; Qian H
    Expert Opin Ther Pat; 2023; 33(9):565-577. PubMed ID: 37947382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening of a novel free fatty acid receptor 1 (FFAR1) agonist peptide by phage display and machine learning based-amino acid substitution.
    Yoshioka K; Yamashita H; Shimizu K; Shimomura S; Shibata T; Miyazaki JI; Honda H
    Biochem Biophys Res Commun; 2021 Apr; 550():177-183. PubMed ID: 33706101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseases.
    Christiansen E; Watterson KR; Stocker CJ; Sokol E; Jenkins L; Simon K; Grundmann M; Petersen RK; Wargent ET; Hudson BD; Kostenis E; Ejsing CS; Cawthorne MA; Milligan G; Ulven T
    Br J Nutr; 2015 Jun; 113(11):1677-88. PubMed ID: 25916176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dysfunctional GPR40/FFAR1 signaling exacerbates pain behavior in mice.
    Nakamoto K; Aizawa F; Miyagi K; Yamashita T; Mankura M; Koyama Y; Kasuya F; Hirasawa A; Kurihara T; Miyata A; Tokuyama S
    PLoS One; 2017; 12(7):e0180610. PubMed ID: 28723961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current status of GPR40/FFAR1 modulators in medicinal chemistry (2016-2019): a patent review.
    Li Z; Zhou Z; Zhang L
    Expert Opin Ther Pat; 2020 Jan; 30(1):27-38. PubMed ID: 31771391
    [No Abstract]   [Full Text] [Related]  

  • 27. Increased glucose metabolism and glycerolipid formation by fatty acids and GPR40 receptor signaling underlies the fatty acid potentiation of insulin secretion.
    El-Azzouny M; Evans CR; Treutelaar MK; Kennedy RT; Burant CF
    J Biol Chem; 2014 May; 289(19):13575-88. PubMed ID: 24675078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose tolerance and free fatty acid metabolism in adults with variations in TCF7L2 rs7903146.
    Lu J; Varghese RT; Zhou L; Vella A; Jensen MD
    Metabolism; 2017 Mar; 68():55-63. PubMed ID: 28183453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addressing free fatty acid receptor 1 (FFAR1) activation using supervised molecular dynamics.
    Atanasio S; Deganutti G; Reynolds CA
    J Comput Aided Mol Des; 2020 Nov; 34(11):1181-1193. PubMed ID: 32851580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential free fatty acid receptor-1 (FFAR1/GPR40) signalling is associated with gene expression or gelatinase granule release in bovine neutrophils.
    Mena SJ; Manosalva C; Carretta MD; Teuber S; Olmo I; Burgos RA; Hidalgo MA
    Innate Immun; 2016 Aug; 22(6):479-89. PubMed ID: 27363707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variation in PPARG is associated with longitudinal change in insulin resistance in Mexican Americans at risk for type 2 diabetes.
    Black MH; Wu J; Takayanagi M; Wang N; Taylor KD; Haritunians T; Trigo E; Lawrence JM; Watanabe RM; Buchanan TA; Xiang AH
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1187-95. PubMed ID: 25584717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Free fatty acid receptor 1 as a novel therapeutic target for type 2 diabetes mellitus-current status.
    Eleazu C; Charles A; Eleazu K; Achi N
    Chem Biol Interact; 2018 Jun; 289():32-39. PubMed ID: 29704509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferator-activated receptor gamma Pro12Ala interacts with the insulin receptor substrate 1 Gly972Arg and increase the risk of insulin resistance and diabetes in the mixed ancestry population from South Africa.
    Vergotine Z; Yako YY; Kengne AP; Erasmus RT; Matsha TE
    BMC Genet; 2014 Jan; 15():10. PubMed ID: 24447396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fasiglifam (TAK-875) has dual potentiating mechanisms via Gαq-GPR40/FFAR1 signaling branches on glucose-dependent insulin secretion.
    Sakuma K; Yabuki C; Maruyama M; Abiru A; Komatsu H; Negoro N; Tsujihata Y; Takeuchi K; Habata Y; Mori M
    Pharmacol Res Perspect; 2016 Jun; 4(3):e00237. PubMed ID: 27433346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined Deletion of Free Fatty-Acid Receptors 1 and 4 Minimally Impacts Glucose Homeostasis in Mice.
    Croze ML; Guillaume A; Ethier M; Fergusson G; Tremblay C; Campbell SA; Maachi H; Ghislain J; Poitout V
    Endocrinology; 2021 Mar; 162(3):. PubMed ID: 33543237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular, but not luminal, activation of FFAR1 (GPR40) stimulates GLP-1 secretion from isolated perfused rat small intestine.
    Christensen LW; Kuhre RE; Janus C; Svendsen B; Holst JJ
    Physiol Rep; 2015 Sep; 3(9):. PubMed ID: 26381015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GPR40/FFAR1 deficient mice increase noradrenaline levels in the brain and exhibit abnormal behavior.
    Aizawa F; Nishinaka T; Yamashita T; Nakamoto K; Kurihara T; Hirasawa A; Kasuya F; Miyata A; Tokuyama S
    J Pharmacol Sci; 2016 Dec; 132(4):249-254. PubMed ID: 27979701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of experimental elevation of free fatty acids on insulin secretion and insulin sensitivity in healthy carriers of the Pro12Ala polymorphism of the peroxisome proliferator--activated receptor-gamma2 gene.
    Stefan N; Fritsche A; Häring H; Stumvoll M
    Diabetes; 2001 May; 50(5):1143-8. PubMed ID: 11334419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FFAR1 is involved in both the acute and chronic effects of palmitate on insulin secretion.
    Kristinsson H; Smith DM; Bergsten P; Sargsyan E
    Endocrinology; 2013 Nov; 154(11):4078-88. PubMed ID: 24035997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
    Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
    Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.